Working with our dental partners Pro3dure Medical, our anti biofilm platform (Remora™) has been incorporated into two of their key medical devices using their MSI® (Multi Species Inhibition) technology. We are delighted to announce that Health Canada have now reviewed and granted licenses for these medical devices. This is a great milestone for Penrhos Bio and further indication of the confidence in the Remora technology.
Congratulations to our partners in Pro3dure and to our licence partner and Key Opinion Leader in the dental space Dr Gary Jernberg, who has been instrumental in this partnership.
